Levels of β-endorphin in the plasma and skin tissue fluids of patients with vitiligo

Journal of Dermatological Science

Volumn 26, Issue 1, 2001, Pages 62-66

  Caixia, Tu ^a   Daming, Zhao ^a   Xiran, Lin ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Plasma; Skin tissue fluid; Vitiligo; endorphin

Indexed keywords

BETA ENDORPHIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; HUMAN; MALE; MEASUREMENT; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; SKIN DEFECT; TISSUE LEVEL; VITILIGO;

BETA-ENDORPHIN; HUMANS; SKIN; VITILIGO;

EID: 0035041048     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(00)00156-0     Document Type: Article

References (19)

1. Neuropeptides in skin
2. Autoantibodies and their clinical significance in a black vitiligo population
3. The immune effects of neuropeptides
4. Vitiligo
5. Neuro-immuno-cutaneous system
6. Physiology of β-endorphins. A close-up view and a review of the literature
7. Plasma α-melanocyte - stimulating hormone, β-endorphin, met-enkephalin, and natrual killer cell activity in vitiligo
8. β-endorphin in the immune system - mediator of pain and stress?
9. β-endorphin and the immune system - possible role in autoimmune diseases
10. Relationship between levels of soluble interleukin-2 receptors and the types and activity of vitiligo
11. Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo
12. Impact of life events on the onset of vitiligo in adults: Preliminary evidence for a psychological dimension in aetiology
13. Neuropeptides in dermatologic therapy
14. Rationale for clinical trials of opiate antagonists in treating patients with personality disorders and self-injurious behavior
15. Implication of the endogenous opioid system in excessive ethanol consumption
16. Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: Implications for the treatment of hepatic encephalopathy with opioid antagonists
17. Effects of naloxone on β-endorphin and cortisol release in sepsis
18. Opioid-immune interactions in autism: Behavioural and immunological Assessment during a double-blind treatment with naltrexone
19. Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients